Literature DB >> 8832557

Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma.

C K Allam1, D G Bostwick, J A Hayes, M P Upton, G G Wade, G F Domanowski, M A Klein, E A Boling, M M Stilmant.   

Abstract

High-grade prostatic intraepithelial neoplasia (PIN) is a strong predictor of carcinoma when identified in small-needle biopsy specimens. However, the diagnostic variability of PIN is unknown. Eight pathologists reviewed 321 prostatic biopsy specimens to assess the variability of the diagnosis of high-grade PIN and carcinoma. All of the specimens were classified as negative, high-grade PIN, suspicious for high-grade PIN, carcinoma, or suspicious for carcinoma, more than one diagnosis was permitted, except for negative. We compared diagnoses made by two observers by pairing them for negative versus high-grade PIN, negative versus carcinoma, high-grade PIN versus carcinoma, and all diagnostic categories together. Mean kappa coefficient values for 28 interobserver combinations were 0.451, 0.845, 0.669, and 0.482, respectively, for each of the four comparison combinations considered. Our results indicate a high level of agreement, "almost perfect" (kappa = 0.81-1.0) for carcinoma, "moderate" (kappa = 0.41-0.60) for high-grade PIN, and "substantial" (kappa = 0.61-0.81) for high-grade PIN versus carcinoma. We found that variability was related to the level of interest in prostatic pathology, the conditions of the study, the subjective application of diagnostic criteria, and the influence of peers and clinical colleagues.

Entities:  

Mesh:

Year:  1996        PMID: 8832557

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

Review 1.  Precursor lesions for prostate cancer.

Authors:  M R Feneley; C Busch
Journal:  J R Soc Med       Date:  1997-10       Impact factor: 5.344

2.  Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer.

Authors:  Nagi Kumar; Theresa Crocker; Tiffany Smith; Julio Pow-Sang; Philippe E Spiess; Kathleen Egan; Gwen Quinn; Michael Schell; Said Sebti; Aslam Kazi; Tian Chuang; Raoul Salup; Mohamed Helal; Gregory Zagaja; Edouard Trabulsi; Jerry McLarty; Tajammul Fazili; Christopher R Williams; Fred Schreiber; Joel Slaton; J Kyle Anderson
Journal:  Contemp Clin Trials       Date:  2011-11-11       Impact factor: 2.226

3.  Diagnostic distance of high grade prostatic intraepithelial neoplasia from normal prostate and adenocarcinoma.

Authors:  R Montironi; R Pomante; P Colanzi; D Thompson; P W Hamilton; P H Bartels
Journal:  J Clin Pathol       Date:  1997-09       Impact factor: 3.411

4.  Global levels of H3K27me3 track with differentiation in vivo and are deregulated by MYC in prostate cancer.

Authors:  Laxmi G Pellakuru; Tsuyoshi Iwata; Bora Gurel; Denise Schultz; Jessica Hicks; Carlise Bethel; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  Am J Pathol       Date:  2012-06-17       Impact factor: 4.307

Review 5.  Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance.

Authors:  R Montironi; R Mazzucchelli; F Algaba; A Lopez-Beltran
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

Review 6.  My approach to intraductal lesions of the prostate gland.

Authors:  M Pickup; T H Van der Kwast
Journal:  J Clin Pathol       Date:  2007-01-19       Impact factor: 3.411

7.  MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.

Authors:  Tsuyoshi Iwata; Denise Schultz; Jessica Hicks; Gretchen K Hubbard; Laura N Mutton; Tamara L Lotan; Carlise Bethel; Matthew T Lotz; Srinivasan Yegnasubramanian; William G Nelson; Chi V Dang; MengMeng Xu; Uzoma Anele; Cheryl M Koh; Charles J Bieberich; Angelo M De Marzo
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

Review 8.  Precursor lesions to prostatic adenocarcinoma.

Authors:  Jonathan I Epstein
Journal:  Virchows Arch       Date:  2008-12-02       Impact factor: 4.064

9.  High-grade prostatic intraepithelial neoplasia.

Authors:  Joseph C Klink; Ranko Miocinovic; Cristina Magi Galluzzi; Eric A Klein
Journal:  Korean J Urol       Date:  2012-05-18

10.  Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer.

Authors:  Wendy Demark-Wahnefried; Stephen L George; Boyd R Switzer; Denise C Snyder; John F Madden; Thomas J Polascik; Mack T Ruffin; Robin T Vollmer
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.